Sounds like a distraction to me. They're supposed to be focused on the high margin side of things, and this ain't it. I'd surely suspect that the take-up and prescription of these products would be multiples lower than that of cannabis so I see the upside.
At least the loan is on good terms so they're generating income from some of that cash.
Sounds like a distraction to me. They're supposed to be focused...
Add VIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.4¢ |
Change
-0.002(2.08%) |
Mkt cap ! $54.13M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.5¢ | 9.4¢ | $53.96K | 549.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 548 | 9.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 129235 | 3 |
View Market Depth
| Last trade - 15.59pm 07/06/2024 (20 minute delay) ? |
|
|||||
|
Last
9.7¢ |
Change
-0.002 ( 3.19 %) |
||||
| Open | High | Low | Volume | ||
| 10.0¢ | 10.0¢ | 9.4¢ | 197479 | ||
| Last updated 15.58pm 07/06/2024 ? | |||||
| VIT (ASX) Chart |